Jacobio Pharmaceuticals Group Co., Ltd. announced that Dr. Shaojing HU will cease to serve as the President of Research and Development of the company with effect from May 12, 2021 but will remain as an executive Director of the company due to other work commitments. Dr. Wenlai ZHOU the Senior Vice President of the Company, will be appointed as the Chief Biologist of the Company and concurrently the Senior Vice President with immediate effect from the date of this announcement.